BillionToOne, Inc. (BLLN)
$94.44+1.47%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4.3B
- Beta
- 0.34
- P/E (TTM)
- 136.85
- Short % float
- 51.61%
- Days to cover
- 3.9
- SI change
- +7.3%
- 1W
- -5.50%
- 1M
- -6.33%
- vs SPY 1W
- -5.36%
- vs SPY 1M
- -8.83%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$56.7BBULLQ 30$395.65-0.53%
- GHSELLGuardant Health, Inc.$21.8BBEARQ 23$162.09-0.43%
- GRALBUYGRAIL Inc.$6.0BRECOVERYQ 68$140.35+2.17%
- VCYTBUYVeracyte, Inc.$3.4BBEARQ 14$43.11-2.07%
- WGSSELLGeneDx Holdings Corp.$1.9BCRISISQ -3$64.96+1.79%
- FLGTSELLFulgent Genetics, Inc.$598MRECOVERYQ 13$21.06-1.91%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on BLLN?
- LOPJLB’s latest quantitative signal on BillionToOne, Inc. (BLLN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BLLN in?
- BillionToOne, Inc. (BLLN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BillionToOne, Inc. (BLLN) do?
- BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product por…